Suggestions
Thomas Zehnder
Medtech ¦ Life Science Entrepreneur and Investor
Professional Background
Thomas Zehnder is a prominent figure in the medical technology and life sciences sectors, known for his passion for product and business model innovations. With over two decades of experience, Thomas has demonstrated significant leadership capabilities, particularly in startup environments, where he has co-founded and managed multiple ventures since 2004. His skill set extends beyond operational roles; he is also a trusted investor and actively serves on the boards of numerous startups and SMEs. His diverse experience across various organizations showcases his in-depth understanding of the medical technology landscape, along with a firm commitment to fostering innovation in healthcare.
In his corporate career spanning eight years, Thomas held several key positions with major players in the health tech industry. His extensive background includes roles such as Former President and CEO at Spinelab Ltd. and Chairman at Micrus Endovascular SA, a Johnson & Johnson company in Switzerland. His leadership trajectory further includes critical positions at AMYRA Biotech AG, Pixium Vision S.A., and Zimmer Biomet, where he played pivotal roles in product development and business strategy.
Through his extensive experience, Thomas has developed a robust insight into investor relations, making substantial contributions to the startups he works with as an advisor and board member. His efforts have led to significant enhancements in operational efficiency and business strategy, ultimately benefiting the healthcare landscape by improving patient care and medical technology solutions.
Education and Achievements
Thomas Zehnder's educational foundation is built on advanced degrees from some of the world's most prestigious institutions. He pursued Executive Education in Private Equity and Venture Capital at Harvard Business School, enabling him to align his startup experience with comprehensive knowledge in funding mechanisms and investment strategies. This education has empowered him to contribute effectively to innovating business models in the healthcare sector.
Moreover, he earned a Doctor of Business Administration (DBA) in Technology Management from the University of St.Gallen, which has provided him with critical insights into technology integration and management at a strategic level. His academic journey began with a Master of Science in Industrial Engineering from ETH Zürich, laying the groundwork for his technical aptitude in understanding medical technologies and their operational requirements.
Thomas's leverage of his education in both hands-on and strategic capacities has been instrumental in his ability to deliver high-impact results for startups and companies in need of transformation.
Achievements
Throughout his career, Thomas Zehnder has achieved numerous accolades and milestones that highlight his expertise and influence in the medical technology industry. He co-founded and served as the Chairman of the Board of Directors at MOWA Healthcare AG, where he guided the company through pivotal stages of growth and strategic investment. At Rheon Medical SA, Thomas contributed significantly during his tenure as Chairman, playing an essential role in strategic direction and operational excellence.
His successful tenure at BlueOcean Ventures SA as a partner showcases his ability to identify and nurture innovative ideas into successful business models. In addition to his strategic roles, Thomas has served as the CFO at AMYRA Biotech AG and has sat on the Boards of various companies, including Testmate Health, Bone Support AB, and RTI Surgical®. His leadership responsibilities have allowed him to forge strong partnerships and drive collaborative projects that enhance the quality of healthcare technology.
Conclusion
Thomas Zehnder is a preeminent leader in medical technology and life sciences innovation, with a rich background in both the corporate and startup world. His extensive education and remarkable professional journey uniquely position him as a significant contributor to the advancement of healthcare solutions. With a commitment to improving patient outcomes and a passion for fostering innovation, Thomas continues to enhance the healthcare landscape through his strategic insights and dedication to excellence.